1.
Eder P, Łykowska-Szuber L, Krela-Kaźmierczak I, Stawczyk-Eder K, Klimczak K, Szymczak A, et al. Safety profile of anti-tumor necrosis factor therapy in inflammatory bowel disease – a single center experience. JMS [Internet]. 2015 Sep. 30 [cited 2024 Apr. 26];84(3):146-51. Available from: https://jms.ump.edu.pl/index.php/JMS/article/view/11